Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.05 | 1.94 |
NAV | ₹18.66 | ₹415.79 |
Fund Started | 06 Oct 2020 | 04 Jun 1999 |
Fund Size | ₹159.61 Cr | ₹3670.62 Cr |
Exit Load | - | Exit load of 0.50% if redeemed within 15 days |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 9.97% | 20.42% |
3 Year | 17.12% | 27.11% |
5 Year | - | 24.68% |
1 Year
3 Year
5 Year
Equity | 99.46% | 97.41% |
Cash | 0.33% | 2.51% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.06% |
Max Healthcare Institute Ltd. | 6.34% |
Cipla Ltd. | 6.04% |
Eli Lilly And Co | 5.77% |
Divi's Laboratories Ltd. | 5.40% |
Apollo Hospitals Enterprise Ltd. | 5.22% |
Dr. Reddy's Laboratories Ltd. | 5.14% |
Lupin Ltd. | 3.55% |
Johnson & Johnson Ltd. | 2.99% |
Torrent Pharmaceuticals Ltd. | 2.92% |
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.98% |
Divi's Laboratories Ltd. | 6.63% |
Max Healthcare Institute Ltd. | 6.28% |
Cipla Ltd. | 5.07% |
Lonza Group Ag | 4.97% |
Lupin Ltd. | 4.80% |
Poly Medicure Ltd. | 3.79% |
Mankind Pharma Ltd. | 3.76% |
Krishna Institute of Medical Sciences Ltd | 3.64% |
Jupiter Life Line Hospitals Ltd. | 3.20% |
Name | Bhavesh Jain | Tanmaya Desai |
Start Date | 01 Oct 2021 | 27 Jun 2011 |
Name
Start Date
Description | The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 06 Oct 2020 | 04 Jun 1999 |
Description
Launch Date